Urinary microRNAs as a new class of noninvasive biomarkers in oncology, nephrology, and cardiology

Methods in Molecular Biology

Volumn 1218, Issue , 2015, Pages 439-463

  Mlcochova, Hana ^a   Hezova, Renata ^a   Meli, Albano C ^a   Slaby, Ondrej ^a  

^a NONE

Author keywords

Biomarker; Bladder cancer; Cardiomyopathy; Diagnosis; Heart failure; MicroRNA; Myocardial infarction; Prognosis; Prostate cancer; Renal cell carcinoma; Urologic cancer; Urothelial cancer

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 100; MICRORNA 107; MICRORNA 10B; MICRORNA 125B; MICRORNA 126; MICRORNA 145; MICRORNA 146A; MICRORNA 155; MICRORNA 15A; MICRORNA 182; MICRORNA 192; MICRORNA 200; MICRORNA 200A; MICRORNA 200C; MICRORNA 205; MICRORNA 20A; MICRORNA 210; MICRORNA 214; MICRORNA 24; MICRORNA 29A; MICRORNA 29B; MICRORNA 31;

ACUTE KIDNEY FAILURE; ARTICLE; BLADDER CANCER; CARDIOLOGY; CARDIOMYOPATHY; CHRONIC KIDNEY DISEASE; DOWN REGULATION; FEMALE; HEART FAILURE; HEART INFARCTION; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; KIDNEY GRAFT REJECTION; NEPHROLOGY; ONCOLOGY; PRIORITY JOURNAL; PROSTATE CANCER; REAL TIME POLYMERASE CHAIN REACTION; RNA STABILITY; UPREGULATION; URINALYSIS; URINARY TRACT CANCER; URINE SEDIMENT;

EID: 84921860103     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-1538-5_26     Document Type: Article

References (101)

1. Mall C, Rocke DM, Durbin-Johnson B, Weiss RH (2013) Stability of miRNA in human urine supports its biomarker potential. Biomark Med 7:623–631
2. Kubiczkova L, Kryukov F, Slaby O, Dementyeva E, Jarkovsky J, Nekvindova J, Radova L, Greslikova H, Kuglik P, Vetesnikova E et al (2013) Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance. Haematologica 7:623–631
3. Redova M, Poprach A, Nekvindova J, Iliev R, Radova L, Lakomy R, Svoboda M, Vyzula R, Slaby O (2012) Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma. J Transl Med 10:55
4. Zheng H, Zhang L, Zhao Y, Yang D, Song F, Wen Y, Hao Q, Hu Z, Zhang W, Chen K (2013) Plasma miRNAs as diagnostic and prognostic biomarkers for ovarian cancer. PLoS One 8:e77853
5. Murtaza M, Dawson SJ, Tsui DW, Gale D, Forshew T, Piskorz AM, Parkinson C, Chin SF, Kingsbury Z, Wong AS et al (2013) Noninvasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature 497:108–112
6. Camussi G, Deregibus MC, Bruno S, Cantaluppi V, Biancone L (2010) Exosomes/ microvesicles as a mechanism of cell-to-cell communication. Kidney Int 78:838–848
7. Camussi G, Deregibus MC, Bruno S, Grange C, Fonsato V, Tetta C (2011) Exosome/ microvesicle-mediated epigenetic reprogramming of cells. Am J Cancer Res 1:98–110
8. Sallustio F, Costantino V, Cox SN, Loverre A, Divella C, Rizzi M, Schena FP (2013) Human renal stem/progenitor cells repair tubular epithelial cell injury through TLR2-driven inhibin-A and microvesicle-shuttled decorin. Kidney Int 83:392–403
9. Hergenreider E, Heydt S, Treguer K, Boettger T, Horrevoets AJ, Zeiher AM, Scheffer MP, Frangakis AS, Yin X, Mayr M et al (2012) Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol 14: 249–256
10. Montecalvo A, Larregina AT, Shufesky WJ, Stolz DB, Sullivan ML, Karlsson JM, Baty CJ, Gibson GA, Erdos G, Wang Z et al (2012) Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood 119:756–766
11. Zernecke A, Bidzhekov K, Noels H, Shagdarsuren E, Gan L, Denecke B, Hristov M, Koppel T, Jahantigh MN, Lutgens E et al (2009) Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal 2:Ra81
12. Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT (2011) MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 13:423–433
13. Beltrami C, Clayton A, Phillips AO, Fraser DJ, Bowen T (2012) Analysis of urinary microRNAs in chronic kidney disease. Biochem Soc Trans 40:875–879
14. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O‘Briant KC, Allen A et al (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105:10513–10518
15. Yun SJ, Jeong P, Kim WT, Kim TH, Lee YS, Song PH, Choi YH, Kim IY, Moon SK, Kim WJ (2012) Cell-free microRNAs in urine as diagnostic and prognostic biomarkers of bladder cancer. Int J Oncol 41:1871–1878
16. Lv LL, Cao Y, Liu D, Xu M, Liu H, Tang RN, Ma KL, Liu BC (2013) Isolation and quantifi cation of microRNAs from urinary exosomes/ microvesicles for biomarker discovery. Int J Biol Sci 9:1021–1031
17. Kirschner MB, van Zandwijk N, Reid G (2013) Cell-free microRNAs: potential biomarkers in need of standardized reporting. Front Genet 4:56
18. Sapre N, Selth LA (2013) Circulating microRNAs as biomarkers of prostate cancer: the state of play. Prostate Cancer 2013:539680
19. Kirschner MB, Kao SC, Edelman JJ, Armstrong NJ, Vallely MP, van Zandwijk N, Reid G (2011) Haemolysis during sample preparation alters microRNA content of plasma. PLoS One 6:e24145
20. Gallo A, Tandon M, Alevizos I, Illei GG (2012) The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS One 7:e30679
21. Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, Mitchell PS, Bennett CF, Pogosova-Agadjanyan EL, Stirewalt DL et al (2011) Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A 108: 5003–5008
22. Turchinovich A, Weiz L, Langheinz A, Burwinkel B (2011) Characterization of extracellular circulating microRNA. Nucleic Acids Res 39:7223–7233
23. Hanke M, Hoefi g K, Merz H, Feller AC, Kausch I, Jocham D, Warnecke JM, Sczakiel G (2010) A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer. Urol Oncol 28:655–661
24. Mengual L, Lozano JJ, Ingelmo-Torres M, Gazquez C, Ribal MJ, Alcaraz A (2013) Using microRNA profi ling in urine samples to develop a non-invasive test for bladder cancer. Int J Cancer 133:2631–2641
25. Snowdon J, Boag S, Feilotter H, Izard J, Siemens DR (2012) A pilot study of urinary microRNA as a biomarker for urothelial cancer. Can Urol Assoc J:1–5
26. Yamada Y, Enokida H, Kojima S, Kawakami K, Chiyomaru T, Tatarano S, Yoshino H, Kawahara K, Nishiyama K, Seki N et al (2011) MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology. Cancer Sci 102:522–529
27. Miranda KC, Bond DT, McKee M, Skog J, Paunescu TG, Da Silva N, Brown D, Russo LM (2010) Nucleic acids within urinary exosomes/ microvesicles are potential biomarkers for renal disease. Kidney Int 78:191–199
28. Huang X, Liang M, Dittmar R, Wang L (2013) Extracellular microRNAs in urologic malignancies: chances and challenges. Int J Mol Sci 14:14785–14799
29. Miah S, Dudziec E, Drayton RM, Zlotta AR, Morgan SL, Rosario DJ, Hamdy FC, Catto JW (2012) An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer. Br J Cancer 107:123–128
30. Waikar SS, Sabbisetti VS, Bonventre JV (2010) Normalization of urinary biomarkers to creatinine during changes in glomerular fi ltration rate. Kidney Int 78:486–494
31. Vrooman OP, Witjes JA (2008) Urinary markers in bladder cancer. Eur Urol 53: 909–916
32. Guancial EA, Bellmunt J, Yeh S, Rosenberg JE, Berman DM (2013) The evolving understanding of microRNA in bladder cancer. Urol Oncol 32(1):41.e31–41.e40
33. Zlotta AR (2013) Bladder cancer: validating what we’ve got. Can Urol Assoc J 7:33–34
34. Saito Y, Friedman JM, Chihara Y, Egger G, Chuang JC, Liang G (2009) Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells. Biochem Biophys Res Commun 379:726–731
35. Wang G, Chan ES, Kwan BC, Li PK, Yip SK, Szeto CC, Ng CF (2012) Expression of microRNAs in the urine of patients with bladder cancer. Clin Genitourin Cancer 10: 106–113
36. Ratert N, Meyer HA, Jung M, Lioudmer P, Mollenkopf HJ, Wagner I, Miller K, Kilic E, Erbersdobler A, Weikert S et al (2013) miRNA profi ling identifi es candidate mirnas for bladder cancer diagnosis and clinical outcome. J Mol Diagn 15:695–705
37. Kim SM, Kang HW, Kim WT, Kim YJ, Yun SJ, Lee SC, Kim WJ (2013) Cell-free microRNA-214 from urine as a biomarker for non-muscle-invasive bladder cancer. Korean J Urol 54:791–796
38. Tolle A, Jung M, Rabenhorst S, Kilic E, Jung K, Weikert S (2013) Identifi cation of microRNAs in blood and urine as tumour markers for the detection of urinary bladder cancer. Oncol Rep 30:1949–1956
39. Hidaka H, Seki N, Yoshino H, Yamasaki T, Yamada Y, Nohata N, Fuse M, Nakagawa M, Enokida H (2012) Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional signifi cance in renal cell carcinoma. Oncotarget 3:44–57
40. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90
41. Obort AS, Ajadi MB, Akinloye O (2013) Prostate-specifi c antigen: any successor in sight? Rev Urol 15:97–107
42. Dijkstra S, Mulders PF, Schalken JA (2013) Clinical use of novel urine and blood based prostate cancer biomarkers: a review. Clin Biochem 47:889–896
43. Ahumada-Tamayo S, Saavedra-Briones D, Cantellano-Orozco M, Salido-Guadarrama A, Rodríguez-Dorantes M, Urdiales-Ortiz A, Hernández-Castellanos V, Merayo-Chalico C, Sánchez-Turati G, Santana-Ríos Z et al (2011) MicroRNA determination in urine for prostate cancer detection in Mexican patients at the Hospital General “Dr. Manuel Gea González”. Rev Mex Urol:213–217
44. Bryant RJ, Pawlowski T, Catto JW, Marsden G, Vessella RL, Rhees B, Kuslich C, Visakorpi T, Hamdy FC (2012) Changes in circulating microRNA levels associated with prostate cancer. Br J Cancer 106:768–774
45. Srivastava A, Goldberger H, Dimtchev A, Ramalinga M, Chijioke J, Marian C, Oermann EK, Uhm S, Kim JS, Chen LN et al (2013) MicroRNA profi ling in prostate cancer—the diagnostic potential of urinary miR-205 and miR-214. PLoS One 8:e76994
46. Gu J, Wang Y, Wu X (2013) MicroRNA in the pathogenesis and prognosis of esophageal cancer. Curr Pharm Des 19:1292–1300
47. Liu J, Mao Q, Liu Y, Hao X, Zhang S, Zhang J (2013) Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients. Chin J Cancer Res 25:46–54
48. Wang N, Li Q, Feng NH, Cheng G, Guan ZL, Wang Y, Qin C, Yin CJ, Hua LX (2013) miR-205 is frequently downregulated in prostate cancer and acts as a tumor suppressor by inhibiting tumor growth. Asian J Androl 15: 735–741
49. Puhr M, Hoefer J, Schafer G, Erb HH, Oh SJ, Klocker H, Heidegger I, Neuwirt H, Culig Z (2012) Epithelial-to-mesenchymal transition leads to docetaxel resistance in prostate cancer and is mediated by reduced expression of miR-200c and miR-205. Am J Pathol 181:2188–2201
50. Chow TF, Youssef YM, Lianidou E, Romaschin AD, Honey RJ, Stewart R, Pace KT, Yousef GM (2010) Differential expression profi ling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis. Clin Biochem 43:150–158
51. Cheng T, Wang L, Li Y, Huang C, Zeng L, Yang J (2013) Differential microRNA expression in renal cell carcinoma. Oncol Lett 6:769–776
52. von Brandenstein M, Pandarakalam JJ, Kroon L, Loeser H, Herden J, Braun G, Wendland K, Dienes HP, Engelmann U, Fries JW (2012) MicroRNA 15a, inversely correlated to PKCalpha, is a potential marker to differentiate between benign and malignant renal tumors in biopsy and urine samples. Am J Pathol 180:1787–1797
53. Guo S, Xu X, Tang Y, Zhang C, Li J, Ouyang Y, Ju J, Bie P, Wang H (2013) miR-15a inhibits cell proliferation and epithelial to mesenchymal transition in pancreatic ductal adenocarcinoma by down-regulating Bmi-1 expression. Cancer Lett 344(1):40–46
54. Bandi N, Vassella E (2011) miR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner. Mol Cancer 10:55
55. Luo Q, Li X, Li J, Kong X, Zhang J, Chen L, Huang Y, Fang L (2013) MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer. Int J Oncol 43:1212–1218
56. Sun Y, Koo S, White N, Peralta E, Esau C, Dean NM, Perera RJ (2004) Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs. Nucleic Acids Res 32:e188
57. Liang M, Liu Y, Mladinov D, Cowley AW Jr, Trivedi H, Fang Y, Xu X, Ding X, Tian Z (2009) MicroRNA: a new frontier in kidney and blood pressure research. Am J Physiol Renal Physiol 297:F553–F558
58. Martin MM, Lee EJ, Buckenberger JA, Schmittgen TD, Elton TS (2006) MicroRNA-155 regulates human angiotensin II type 1 receptor expression in fi broblasts. J Biol Chem 281:18277–18284
59. Zen K, Zhang CY (2012) Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers. Med Res Rev 32:326–348
60. Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, Lee MJ, Galas DJ, Wang K (2010) The microRNA spectrum in 12 body fl uids. Clin Chem 56:1733–1741
61. Caubet C, Lacroix C, Decramer S, Drube J, Ehrich JH, Mischak H, Bascands JL, Schanstra JP (2009) Advances in urinary proteome analysis and biomarker discovery in pediatric renal disease. Pediatr Nephrol 25:27–35
62. Matheson A, Willcox MD, Flanagan J, Walsh BJ (2010) Urinary biomarkers involved in type 2 diabetes: a review. Diabetes Metab Res Rev 26:150–171
63. Lan YF, Chen HH, Lai PF, Cheng CF, Huang YT, Lee YC, Chen TW, Lin H (2012) MicroRNA-494 reduces ATF3 expression and promotes AKI. J Am Soc Nephrol 23: 2012–2023
64. Ichii O, Otsuka S, Sasaki N, Namiki Y, Hashimoto Y, Kon Y (2012) Altered expression of microRNA miR-146a correlates with the development of chronic renal infl ammation. Kidney Int 81:280–292
65. Du B, Ma LM, Huang MB, Zhou H, Huang HL, Shao P, Chen YQ, Qu LH (2010) High glucose down-regulates miR-29a to increase collagen IV production in HK-2 cells. FEBS Lett 584:811–816
66. Chandrasekaran K, Karolina DS, Sepramaniam S, Armugam A, Wintour EM, Bertram JF, Jeyaseelan K (2012) Role of microRNAs in kidney homeostasis and disease. Kidney Int 81:617–627
67. Wang B, Komers R, Carew R, Winbanks CE, Xu B, Herman-Edelstein M, Koh P, Thomas M, Jandeleit-Dahm K, Gregorevic P et al (2011) Suppression of microRNA-29 expression by TGF-beta1 promotes collagen expression and renal fi brosis. J Am Soc Nephrol 23:252–265
68. Wang G, Kwan BC, Lai FM, Choi PC, Chow KM, Li PK, Szeto CC (2009) Intrarenal expression of microRNAs in patients with IgA nephropathy. Lab Invest 90:98–103
69. Wang G, Kwan BC, Lai FM, Chow KM, Li PK, Szeto CC (2012) Urinary miR-21, miR- 29, and miR-93: novel biomarkers of fi brosis. Am J Nephrol 36:412–418
70. Neal CS, Michael MZ, Pimlott LK, Yong TY, Li JY, Gleadle JM (2011) Circulating microRNA expression is reduced in chronic kidney disease. Nephrol Dial Transplant 26: 3794–3802
71. Scian MJ, Maluf DG, David KG, Archer KJ, Suh JL, Wolen AR, Mba MU, Massey HD, King AL, Gehr T et al (2011) MicroRNA profi les in allograft tissues and paired urines associate with chronic allograft dysfunction with IF/TA. Am J Transplant 11:2110–2122
72. Lorenzen JM, Volkmann I, Fiedler J, Schmidt M, Scheffner I, Haller H, Gwinner W, Thum T (2011) Urinary miR-210 as a mediator of acute T-cell mediated rejection in renal allograft recipients. Am J Transplant 11:2221–2227
73. Maluf DG, Dumur CI, Suh JL, Scian MJ, King AL, Cathro H, Lee JK, Gehrau RC, Brayman KL, Gallon L et al (2013) The urine microRNA profi le may help monitor post- transplant renal graft function. Kidney Int 85:439–449
74. Konta T, Ichikawa K, Suzuki K, Kudo K, Satoh H, Kamei K, Nishidate E, Kubota I (2013) A microarray analysis of urinary microRNAs in renal diseases. Clin Exp Nephrol. Nov 6
75. Luo Y, Wang C, Chen X, Zhong T, Cai X, Chen S, Shi Y, Hu J, Guan X, Xia Z et al (2013) Increased serum and urinary microRNAs in children with idiopathic nephrotic syndrome. Clin Chem 59:658–666
76. Zhou H, Souto-Adeva G, Hardwick D, Illei GG (2011) Potential Biomarkers of Renal Disease Activity in Lupus Nephritis. [Abstract]. Arthritis Rheum 63:2287
77. Kavsak PA, MacRae AR, Yerna MJ, Jaffe AS (2009) Analytic and clinical utility of a nextgeneration, highly sensitive cardiac troponin I assay for early detection of myocardial injury. Clin Chem 55:573–577
78. Keller T, Zeller T, Peetz D, Tzikas S, Roth A, Czyz E, Bickel C, Baldus S, Warnholtz A, Frohlich M et al (2009) Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 361:868–877
79. Hamm CW (1994) New serum markers for acute myocardial infarction. N Engl J Med 331:607–608
80. de Winter RJ, Koster RW, Sturk A, Sanders GT (1995) Value of myoglobin, troponin T, and CK-MBmass in ruling out an acute myocardial infarction in the emergency room. Circulation 92:3401–3407
81. Devaux Y, Vausort M, McCann GP, Kelly D, Collignon O, Ng LL, Wagner DR, Squire IB (2013) A panel of 4 microRNAs facilitates the prediction of left ventricular contractility after acute myocardial infarction. PLoS One 8: e70644
82. Fan KL, Zhang HF, Shen J, Zhang Q, Li XL (2013) Circulating microRNAs levels in Chinese heart failure patients caused by dilated cardiomyopathy. Indian Heart J 65:12–16
83. Li C, Pei F, Zhu X, Duan DD, Zeng C (2012) Circulating microRNAs as novel and sensitive biomarkers of acute myocardial Infarction. Clin Biochem 45:727–732
84. Long G, Wang F, Duan Q, Yang S, Chen F, Gong W, Yang X, Wang Y, Chen C, Wang DW (2012) Circulating miR-30a, miR-195 and let-7b associated with acute myocardial infarction. PLoS One 7:e50926
85. Tijsen AJ, Creemers EE, Moerland PD, de Windt LJ, van der Wal AC, Kok WE, Pinto YM (2010) MiR423-5p as a circulating biomarker for heart failure. Circ Res 106:1035–1039
86. Corsten MF, Dennert R, Jochems S, Kuznetsova T, Devaux Y, Hofstra L, Wagner DR, Staessen JA, Heymans S, Schroen B (2010) Circulating MicroRNA-208b and MicroRNA-499 refl ect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet 3:499–506
87. Gidlof O, Andersson P, van der Pals J, Gotberg M, Erlinge D (2011) Cardiospecifi c microRNA plasma levels correlate with troponin and cardiac function in patients with ST elevation myocardial infarction, are selectively dependent on renal elimination, and can be detected in urine samples. Cardiology 118:217–226
88. Care A, Catalucci D, Felicetti F, Bonci D, Addario A, Gallo P, Bang ML, Segnalini P, Gu Y, Dalton ND et al (2007) MicroRNA-133 controls cardiac hypertrophy. Nat Med 13: 613–618
89. Dong DL, Chen C, Huo R, Wang N, Li Z, Tu YJ, Hu JT, Chu X, Huang W, Yang BF (2010) Reciprocal repression between microRNA-133 and calcineurin regulates cardiac hypertrophy: a novel mechanism for progressive cardiac hypertrophy. Hypertension 55:946–952
90. Bostjancic E, Zidar N, Stajer D, Glavac D (2010) MicroRNAs miR-1, miR-133a, miR- 133b and miR-208 are dysregulated in human myocardial infarction. Cardiology 115:163–169
91. Satoh M, Minami Y, Takahashi Y, Tabuchi T, Nakamura M (2010) Expression of microRNA-208 is associated with adverse clinical outcomes in human dilated cardiomyopathy. J Card Fail 16:404–410
92. Cheng Y, Wang X, Yang J, Duan X, Yao Y, Shi X, Chen Z, Fan Z, Liu X, Qin S et al (2012) A translational study of urine miRNAs in acute myocardial infarction. J Mol Cell Cardiol 53:668–676
93. Zhou X, Mao A, Wang X, Duan X, Yao Y, Zhang C (2013) Urine and serum microRNA-1 as novel biomarkers for myocardial injury in open-heart surgeries with cardiopulmonary bypass. PLoS One 8:e62245
94. Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, He J, Qin YW, Jing Q (2010) Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 31:659–666
95. Goren Y, Kushnir M, Zafrir B, Tabak S, Lewis BS, Amir O (2012) Serum levels of microRNAs in patients with heart failure. Eur J Heart Fail 14:147–154
96. Heymans S, Corsten MF, Verhesen W, Carai P, van Leeuwen RE, Custers K, Peters T, Hazebroek M, Stoger L, Wijnands E et al (2013) Macrophage microRNA-155 promotes cardiac hypertrophy and failure. Circulation 128:1420–1432
97. Saikumar J, Hoffmann D, Kim TM, Gonzalez VR, Zhang Q, Goering PL, Brown RP, Bijol V, Park PJ, Waikar SS et al (2012) Expression, circulation, and excretion profi le of microRNA-21, -155, and -18a following acute kidney injury. Toxicol Sci 129:256–267
98. Wang G, Kwan BC, Lai FM, Chow KM, Li PK, Szeto CC (2011) Elevated levels of miR- 146a and miR-155 in kidney biopsy and urine from patients with IgA nephropathy. Dis Markers 30:171–179
99. Wang G, Tam LS, Li EK, Kwan BC, Chow KM, Luk CC, Li PK, Szeto CC (2010) Serum and urinary cell-free MiR-146a and MiR- 155 in patients with systemic lupus erythematosus. J Rheumatol 37:2516–2522
100. Wang K, Zhang S, Weber J, Baxter D, Galas DJ (2010) Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res 38:7248–7259
101. Lv LL, Cao YH, Ni HF, Xu M, Liu D, Liu H, Chen PS, Liu BC (2013) MicroRNA-29c in urinary exosome/microvesicle as a biomarker of renal fibrosis. Am J Physiol Renal Physiol 305:F1220–F1227